Skip to main content

Advertisement

Volume 3 Supplement 1

ESICM LIVES 2015

Prophylaxis of thromboembolic disease: patient safety protocoL

Article metrics

  • 265 Accesses

Introduction

Critically ill patients have a high risk of deep venous thrombosis and pulmonary embolism, which comprise venous thromboembolic disease (VTED). Prevention during critical illness is a widely used quality metric and safety initiative for these patients.

Objective

To evaluate the effectiveness of a bundle of VTED prophylactic measures upon completion of a project aim to improve patient safety in this entity.

Methods

We designed a three phases prospective study of patients admitted to a general ICU of a tertiary university hospital. During first 4 months, weekly collection days are established, gathering demographic variables, reason for admission, severity scores, risk factors for hemorrhage and thrombosis as well as VTED prophylactic measures prescribed. Data were analyzed using a Failure Mode and Effects Analysis (FMEA) from which a set of measures were developed and the implementation of a VTED prophylaxis protocol. After that, we collected data during 5 months to compare the effectiveness of the protocol. Finally, a checklist was introduced to facilitated the adherence to these measures. The impact of this checklist was evaluated for 2 more months. All results were analyzed using the SPSS v22.0.0 statistical analysis software.

Results

In the first period we enrolled 59 patients, 42 of them (71.2%) received prophylaxis for VTE (63.4% had pharmacological prophylaxis and 34.1% mechanical) and 2.4% received dual prophylaxis. Seventeen patients (28.8%) received no prophylaxis, 2 of them had contraindication to any type of VTED thromboprophylaxis.

Post-FMEA, we enrolled 97 patients, 89 of them (91.7%) received prophylaxis for VTED: 55% received pharmacological prophylaxis and 45% mechanical devices. Dual prophylaxis was received by 6.25% of patients. From those who received mechanical devices, 67.9% received compression stockings. Seven patients (8.2%) presented high risk of bleeding and did not receive prophylaxis. One patient had contraindication for both types of measures.

Post checklist we included 40 patients, 39 of them (97.5%) of them received prophylactic measures: 73.5% received pharmacological prophylaxis and 32.5% mechanical devices. Dual prophylaxis were applied in 25% of patients. Only 1 patient (2.5%) had double contraindication for VTED measures.

Conclusions

The number of patients with high risk of thrombosis as well as those who receive dual prophylaxis has increased after the implemetation of a VTED prophylaxis protocol. The development of a daily checklist could be a useful tool to monitor adherence to this protocol. All of these measures are expected to improve patient safety.

Author information

Correspondence to R Viejo Moreno.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Viejo Moreno, R., Talayero Giménez de Azcárate, M., Barea Mendoza, J. et al. Prophylaxis of thromboembolic disease: patient safety protocoL. ICMx 3, A736 (2015) doi:10.1186/2197-425X-3-S1-A736

Download citation

Keywords

  • Pulmonary Embolism
  • Deep Venous Thrombosis
  • Mechanical Device
  • Statistical Analysis Software
  • Thromboembolic Disease